SYRMA.NS(SYRMA.NS)
SYRMA.NS
NSE • Last print unknown ago
$1606.30—Stale · unknown old
No analyst ratings available
No analyst price targets available for SYRMA.NS
Analyst coverage may not be available for this symbol
No recent analyst actions
| Metric | FY2027E | FY2028E | FY2029E | FY2030E |
|---|---|---|---|---|
| Revenue Avg | $66.78B | $88.46B | $114.04B | $124.29B |
| Low | $62.80B | $81.24B | $104.47B | $114.92B |
| High | $72.13B | $94.96B | $129.02B | $135.63B |
| EBITDA Avg | $8.42B | $11.70B | $16.08B | $20.06B |
| Low | $7.89B | $10.24B | $14.75B | $18.61B |
| High | $9.36B | $13.27B | $17.65B | $21.82B |
| EBIT Avg | $6.79B | $9.13B | $12.39B | $15.33B |
| Low | $6.26B | $7.67B | $11.07B | $13.88B |
| High | $7.73B | $10.70B | $13.96B | $17.09B |
| Net Income Avg | $4.32B | $5.92B | $8.16B | $10.18B |
| Low | $3.96B | $4.93B | $7.25B | $9.18B |
| High | $4.96B | $7.00B | $9.24B | $11.38B |
| EPS Avg | $22.76 | $30.77 | $42.65 | $53.20 |
| Low | $20.69 | $25.75 | $37.91 | $47.99 |
| High | $25.94 | $36.59 | $48.28 | $59.51 |
| Analysts (Rev / EPS) | 17 / 16 | 18 / 16 | 11 / 9 | 6 / 3 |
| Metric | Q3 2026 | Q4 2026 | Q1 2027 |
|---|---|---|---|
| Revenue Avg | $14.93B | $16.77B | $19.38B |
| Low | $14.93B | $16.77B | $19.38B |
| High | $14.93B | $16.77B | $19.38B |
| EBITDA Avg | $1.77B | $2.06B | $2.64B |
| Low | $1.77B | $2.06B | $2.64B |
| High | $1.77B | $2.06B | $2.64B |
| EBIT Avg | $1.50B | $1.74B | $2.28B |
| Low | $1.50B | $1.74B | $2.28B |
| High | $1.50B | $1.74B | $2.28B |
| Net Income Avg | $953M | $1.12B | $1.48B |
| Low | $953M | $1.12B | $1.48B |
| High | $953M | $1.12B | $1.48B |
| EPS Avg | $4.95 | $5.80 | $7.70 |
| Low | $4.95 | $5.80 | $7.70 |
| High | $4.95 | $5.80 | $7.70 |
| Analysts (Rev / EPS) | 1 / 1 | 1 / 1 | 1 / 1 |